Imatinib | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Imatinib
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Imatinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

101 API Suppliers, 35 USDMF, 21 CEP/COS, 7 JDMF, 15 EU WC, 31 KDMF, 21 NDC API, 63 Listed Suppliers, $ API Reference Price

101 API Suppliers
35 USDMF
21 CEP/COS
7 JDMF
15 EU WC
31 KDMF
21 NDC API
63 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

45 Intermediate Suppliers

45 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

574 FDF Dossiers, 33 FDA Orange Book, 101 Europe, 20 Canada, 352 Australia, 16 South Africa, 52 Listed Dossiers

574 FDF Dossiers
33 FDA Orange Book
101 Europe
20 Canada
352 Australia
16 South Africa
52 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 400MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 400MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 10 DKSH, 4 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 17 BASF, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 33 Disintegrants & Superdisintegrants, 32 Direct Compression, 28 Controlled & Modified Release, 22 Granulation, 21 Thickeners and Stabilizers, 19 Lubricants & Glidants, 17 Chewable & Orodispersible Aids, 14 Taste Masking, 14 Solubilizers, 13 Film Formers & Plasticizers, 12 Co-Processed Excipients, 10 Topical, 10 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Rheology Modifiers, 1 Surfactant & Foaming Agents

76 Fillers, Diluents & Binders
52 Coating Systems & Additives
33 Disintegrants & Superdisintegrants
32 Direct Compression
28 Controlled & Modified Release
22 Granulation
21 Thickeners and Stabilizers
19 Lubricants & Glidants
17 Chewable & Orodispersible Aids
14 Taste Masking
14 Solubilizers
13 Film Formers & Plasticizers
12 Co-Processed Excipients
10 Topical
10 Parenteral
5 Empty Capsules
5 API Stability Enhancers
5 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents
3 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

153 NEWS #PharmaBuzz

153 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 43 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
43 Finished Drug Prices
10 Annual Reports

MARKET PLACE

20 APIs, 15 FDF Dossiers

20 APIs
15 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 8 Health Canada Patents

1 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 6 Others

1 EDQM
6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 950 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1SHORLA ONCOLOGY

filter Patent Number Reset all filters

1 All

01 111957681

filter API Patent Reset all filters

1 All

01 1Blank

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12040-04-27

Product Main Page

01

SHORLA ONCOLOGY

IMATINIB MESYLATE

The Generic Rx Session

Not Confirmed

SHORLA ONCOLOGY

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2040-04-27

IMATINIB MESYLATE

US Patent Number : 11957681

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 219097

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-04-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!